Navigation Links
Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008
Date:1/29/2008

IRVINE, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a global leader in products and technologies to treat advanced cardiovascular disease, plans to announce its operating results for the quarter ended December 31, 2007 after the market closes on Tuesday, February 5, 2008 and will host a conference call at 5:00 p.m. ET that day to discuss its results.

To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 270419. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at http://www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.

About Edwards Lifesciences

Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the U.S. Patent and Trademark Office.


'/>"/>
SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
2. Edwards Lifesciences Completes Acquisition of CardioVations Product Line
3. Edwards Lifesciences Forecasts Strong Growth in 2008
4. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
5. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
6. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
7. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
8. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
9. Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28, 2008
10. Sigma-Aldrich Corporations 4th Quarter 2007 Earnings Conference Call
11. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... FL (PRWEB) , ... August 17, 2017 , ... ... that the stock market news outlet had provided a research update on Aytu ... nasally administered TRT product. , According to Soulstring, prescription rates for Natesto® have ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... While art ... are much more closely connected than one might think. A Mesh Is Also ... open at the University City Science Center’s Esther Klein Gallery (EKG) on August 17 ...
(Date:8/15/2017)... Calif. , Aug. 15, 2017 After spending the ... and support with crowdsourced data collection, GeneFo now offers this platform ... in aligning and amplifying support, adherence, and data collection vis a ... medical foundations mark the successful launch of this offer. ... GeneFo ...
(Date:8/15/2017)... , ... August 15, 2017 , ... ... family of 6” modular downlights designed to stay tightly sealed and perform efficiently ... where damp and wet location listings just aren't enough, such as: hospitals; behavioral ...
Breaking Biology Technology:
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
(Date:4/13/2017)... 13, 2017 According to a new market research ... Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and ... is expected to grow from USD 14.30 Billion in 2017 to USD ... 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
Breaking Biology News(10 mins):